Page last updated: 2024-12-11

isopryn, phenylbutazone drug combination

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

isopryn, phenylbutazone drug combination: contains isopryn & phebuzine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6441309
MeSH IDM0044658

Synonyms (7)

Synonym
tomanil
tomanol
isopryn - phenybutazone
isopryn, phenylbutazone drug combination
3,5-pyrazolidinedione, 4-butyl-1,2-diphenyl-, mixt. with (e)-1-(4-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-hydroxy-6-methoxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)-2-propen-1-one and 1,2-dihydro-1,5-dimethyl-4-((1-methylethyl)amin
8058-14-8
4-butyl-1,2-diphenylpyrazolidine-3,5-dione;1,5-dimethyl-2-phenyl-4-(propan-2-ylamino)pyrazol-3-one;(e)-3-(3-hydroxy-4-methoxyphenyl)-1-[2-hydroxy-6-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymet

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"7%) and a prolongation of the elimination half-life of penicillin (17."( Effect of Tomanol on the pharmacokinetics and tissue distribution of penicillin G in dairy cows.
Hekman, P; Nouws, JF; van Ginneken, CA, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.41 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]